OBJECTIVE: To describe the treatment and assessment of emergency department @entity390 and @entity391 (EDNV) in Australasia by Fellows of the Australasian College for Emergency Medicine (FACEM). To determine the influence of various factors on FACEM anti-emetic choice. To compare the influence of drug effectiveness, side effects, cost and pharmacy directives on adult EDNV anti-emetic choice between FACEM choosing the two most common first-line agents. METHODS: A cross-sectional survey of all FACEM practising in Australasian ED was conducted by mail-out in February 2009. RESULTS: Of all FACEM surveyed 48.7% (532/1092) responded. The most common first-line drugs for adult EDNV were @entity1769 (87.3%, 453/519), 5HT3 antagonists (7.9%, 41/519) and @entity6916 (2.3%, 12/519). For paediatric EDNV, the most common first-line agents were 5HT3 antagonists (86.2%, 307/356), @entity1769 (6.7%, 24/356) and @entity4489 (5.1%, 18/356). For most FACEM anti-emetic choice was highly influenced by perceived drug efficacy (96.1%) and side effects (82.5%), and 32.9% of FACEM were highly influenced by drug cost. Few FACEM reported ED anti-emetic protocols for adults (13.0%) or @entity1 (16.7%) in their ED. FACEM seldom used scales or tools to measure EDNV severity in adult (2.5%) or paediatric (3.4%) @entity1 . CONCLUSIONS: Fellows of the Australasian College for Emergency Medicine anti-emetic choice in Australasian ED has been described. The main influences on anti-emetic choice were @entity1 age, perceived drug efficacy and drug side-effect profiles.

Treatment and assessment of emergency department @entity390 and XXXX in Australasia: a survey of anti-emetic management.

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient'] @entity4489 :: ('MESH:D011398', 'Chemical') :: ['promethazine'] @entity6916 :: ('MESH:D011346', 'Chemical') :: ['prochlorperazine'] @entity390 :: ('MESH:D009325', 'Disease') :: ['nausea'] @entity391 :: ('MESH:D014839', 'Disease') :: ['vomiting'] @entity1769 :: ('MESH:D008787', 'Chemical') :: ['metoclopramide']
@entity391 :: (MESH:D014839,Disease) :: ['vomiting']
